Reni Benjamin
Stock Analyst at Citizens JMP
(0.06)
# 4,853
Out of 5,133 analysts
799
Total ratings
33.9%
Success rate
-9.6%
Average return
Main Sectors:
Stocks Rated by Reni Benjamin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Reiterated: Buy | $32 → $39 | $26.24 | +48.63% | 2 | Nov 13, 2026 | |
| IOVA Iovance Biotherapeutics | Reiterated: Buy | $8 → $12 | $7.76 | +54.64% | 51 | Nov 6, 2026 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $405 → $463 | $416.54 | +11.15% | 12 | Nov 6, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | $10 → $4 | $0.7738 | +416.93% | 2 | Sep 23, 2026 | |
| STRO Sutro Biopharma | Reiterated: Buy | $35 → $41 | $9.82 | +317.52% | 47 | Apr 23, 2026 | |
| WHWK Whitehawk Therapeutics | Initiated Coverage: Buy | $8 | $3.06 | +161.44% | 1 | Apr 16, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $5 → $8 | $0.8387 | +853.86% | 36 | Apr 14, 2026 | |
| BCYC Bicycle Therapeutics | Reiterated: Buy | $12 → $8 | $3.37 | +137.39% | 37 | Mar 18, 2026 | |
| IMMP Immutep | Downgraded: Hold | n/a | $3.48 | - | 2 | Mar 13, 2026 | |
| PRLD Prelude Therapeutics | Reiterated: Buy | $3 → $6 | $3.45 | +73.91% | 15 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $7.84 | +193.37% | 1 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $14.30 | +137.76% | 1 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $31 | $10.02 | +209.38% | 1 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.9803 | - | 12 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $8 | $2.02 | n/a | 16 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.78 | n/a | 28 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $7.77 | n/a | 41 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $120.97 | n/a | 105 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $14.15 | n/a | 8 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.08 | n/a | 7 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $83.30 | n/a | 6 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $16.12 | n/a | 27 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.10 | n/a | 10 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0008 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.40 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.18 | n/a | 20 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $6 | $0.03 | n/a | 19 | May 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.20 | n/a | 24 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $110 | $57.23 | n/a | 1 | Apr 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $5 | $0.9146 | n/a | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 → $57 | $26.18 | n/a | 14 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $96 → $94 | $7.64 | n/a | 12 | Feb 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $0.4742 | n/a | 4 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $5 | $1.63 | n/a | 25 | Nov 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $1.73 | n/a | 9 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $10 | $13.68 | n/a | 17 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $13 | $1.87 | n/a | 16 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $64.51 | n/a | 25 | Aug 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.1271 | n/a | 8 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.28 | n/a | 21 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.02 | n/a | 14 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.86 | n/a | 10 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0132 | n/a | 7 | Jun 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.0002 | n/a | 1 | May 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.629 | n/a | 7 | May 21, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 5 | May 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $3 | $1.42 | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $5 | $0.771 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $12 | $9.53 | n/a | 7 | Mar 19, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.05 | n/a | 4 | Feb 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $6.73 | n/a | 6 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $0.000001 | n/a | 6 | Dec 11, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.12 | n/a | 3 | Oct 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $35.59 | n/a | 1 | May 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 | $16.07 | n/a | 1 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.967 | n/a | 2 | Oct 12, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.32 | n/a | 2 | May 10, 2010 |
Zymeworks
Nov 13, 2026
Reiterated: Buy
Price Target: $32 → $39
Current: $26.24
Upside: +48.63%
Iovance Biotherapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $8 → $12
Current: $7.76
Upside: +54.64%
BeOne Medicines AG
Nov 6, 2026
Reiterated: Buy
Price Target: $405 → $463
Current: $416.54
Upside: +11.15%
Compass Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $10 → $4
Current: $0.7738
Upside: +416.93%
Sutro Biopharma
Apr 23, 2026
Reiterated: Buy
Price Target: $35 → $41
Current: $9.82
Upside: +317.52%
Whitehawk Therapeutics
Apr 16, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $3.06
Upside: +161.44%
Allogene Therapeutics
Apr 14, 2026
Reiterated: Buy
Price Target: $5 → $8
Current: $0.8387
Upside: +853.86%
Bicycle Therapeutics
Mar 18, 2026
Reiterated: Buy
Price Target: $12 → $8
Current: $3.37
Upside: +137.39%
Immutep
Mar 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.48
Upside: -
Prelude Therapeutics
Mar 11, 2026
Reiterated: Buy
Price Target: $3 → $6
Current: $3.45
Upside: +73.91%
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $7.84
Upside: +193.37%
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $14.30
Upside: +137.76%
Jan 29, 2026
Initiated Coverage: Buy
Price Target: $31
Current: $10.02
Upside: +209.38%
Dec 19, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.9803
Upside: -
Oct 30, 2025
Reiterated: Buy
Price Target: $5 → $8
Current: $2.02
Upside: n/a
Oct 8, 2025
Reiterated: Hold
Price Target: n/a
Current: $2.78
Upside: n/a
Sep 30, 2025
Reiterated: Buy
Price Target: $24
Current: $7.77
Upside: n/a
Sep 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $120.97
Upside: n/a
Sep 8, 2025
Reiterated: Buy
Price Target: $40
Current: $14.15
Upside: n/a
Aug 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $6.08
Upside: n/a
May 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $83.30
Upside: n/a
Apr 21, 2025
Reiterated: Buy
Price Target: $2
Current: $16.12
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $2.10
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.0008
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $6.40
Upside: n/a
May 10, 2019
Downgraded: Hold
Price Target: n/a
Current: $8.18
Upside: n/a
May 7, 2019
Reiterated: Buy
Price Target: $16 → $6
Current: $0.03
Upside: n/a
May 2, 2019
Reiterated: Hold
Price Target: n/a
Current: $2.20
Upside: n/a
Apr 9, 2019
Initiated Coverage: Buy
Price Target: $110
Current: $57.23
Upside: n/a
Mar 18, 2019
Reiterated: Buy
Price Target: $6 → $5
Current: $0.9146
Upside: n/a
Mar 1, 2019
Reiterated: Buy
Price Target: $73 → $57
Current: $26.18
Upside: n/a
Feb 5, 2019
Upgraded: Buy
Price Target: $96 → $94
Current: $7.64
Upside: n/a
Dec 13, 2018
Reiterated: Buy
Price Target: $21
Current: $0.4742
Upside: n/a
Nov 15, 2018
Upgraded: Buy
Price Target: $5
Current: $1.63
Upside: n/a
Nov 14, 2018
Upgraded: Buy
Price Target: n/a
Current: $1.73
Upside: n/a
Oct 12, 2018
Reiterated: Buy
Price Target: $11 → $10
Current: $13.68
Upside: n/a
Aug 28, 2018
Reiterated: Buy
Price Target: $13 → $13
Current: $1.87
Upside: n/a
Aug 14, 2018
Reiterated: Buy
Price Target: $22
Current: $64.51
Upside: n/a
Aug 10, 2018
Reiterated: Hold
Price Target: n/a
Current: $0.1271
Upside: n/a
Aug 7, 2018
Reiterated: Hold
Price Target: n/a
Current: $1.28
Upside: n/a
Aug 7, 2018
Reiterated: Hold
Price Target: n/a
Current: $6.02
Upside: n/a
Dec 18, 2017
Rated: Hold
Price Target: n/a
Current: $7.86
Upside: n/a
Jun 4, 2015
Reiterated: Buy
Price Target: $6
Current: $0.0132
Upside: n/a
May 26, 2015
Initiated Coverage: Buy
Price Target: $13
Current: $0.0002
Upside: n/a
May 21, 2015
Reiterated: Buy
Price Target: $8
Current: $0.629
Upside: n/a
May 15, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $7 → $3
Current: $1.42
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $9 → $5
Current: $0.771
Upside: n/a
Mar 19, 2015
Reiterated: Buy
Price Target: $8 → $12
Current: $9.53
Upside: n/a
Feb 18, 2015
Reiterated: Buy
Price Target: $4
Current: $1.05
Upside: n/a
Jan 9, 2015
Reiterated: Buy
Price Target: $6
Current: $6.73
Upside: n/a
Dec 11, 2014
Reiterated: Buy
Price Target: $40
Current: $0.000001
Upside: n/a
Oct 13, 2014
Reiterated: Hold
Price Target: n/a
Current: $1.12
Upside: n/a
May 5, 2014
Initiated Coverage: Buy
Price Target: $17
Current: $35.59
Upside: n/a
Jul 24, 2013
Downgraded: Hold
Price Target: $39
Current: $16.07
Upside: n/a
Oct 12, 2010
Reiterated: Buy
Price Target: $9
Current: $0.967
Upside: n/a
May 10, 2010
Reiterated: Buy
Price Target: n/a
Current: $8.32
Upside: n/a